Table 4 Evaluation of expression in the second stage of blood testing with 27 samples
Candidate genes | Fold change cancer/normal | P value | Significantly different expression of ccRCC vs. normal in 27 pax blood samples |
|---|---|---|---|
EGLN3 | −1.26 | 0.215 | No |
CCND1 | −1.55 | 0.039 | Downregulated in ccRCC |
CAV2 | 1.16 | 0.497 | No |
ESM1 | −1.21 | 0.668 | No |
CDK18 | −2.10 | 0.001 | Downregulated in ccRCC |
TMEM45A | −1.04 | 0.734 | No |
LOX | −1.31 | 0.668 | No, tendency towards upregulation in metastatic ccRCC |
NOL3 | −1.05 | 0.641 | No |
FABP7 | −1.13 | 0.671 | No |